G9562 Patients who had a follow-up evaluation conducted at least every three months during opioid therapy

Short descriptor: Foll-up eval q3mo opiod tx

⚠ Terminated HCPCS Level II 2026
Terminated Code
G9562 was terminated as of 2021-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open G9562 in the app →

Look up G9562 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

G9562 is the HCPCS Level II code for Patients who had a follow-up evaluation conducted at least every three months during opioid therapy (2026). It belongs to Section G — Procedures / Professional Services (Temporary). Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Not separately priced by Part B (indicator 00)
Type of Service
Medical care
Effective Date
2022-01-01
Termination Date
2021-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference G9562 with the canonical source and edition:

G9562 — Patients who had a follow-up evaluation conducted at least every three months during opioid therapy. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/G9562

Canonical URL: https://icd10codingpro.com/hcpcs-codes/G9562

Related Codes in Section G

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial